BRIEF published on 09/19/2024 at 14:35, 1 year 2 months ago Lehman Brothers UK Cap Fdg IV LP: Notice to Holders of Preferred Securities Liquidation Notice Capital Funding Lehman Brothers Preferred Securities
BRIEF published on 09/19/2024 at 14:35, 1 year 2 months ago Lehman Brothers UK Cap Fdg IV LP : Avis aux détenteurs de titres privilégiés Liquidation Financement En Capital Lehman Brothers Titres Privilégiés Avis
PRESS RELEASE published on 09/19/2024 at 14:30, 1 year 2 months ago Lehman Brothers UK Cap Fdg IV LP: Notice to the Holders of the Preferred Securities Lehman Brothers UK Cap Fdg IV LP issues notice regarding liquidation of LB GP No.1 Ltd and implications for LP IV ECAPS holders. Important information for securities owners Securities Liquidation Notice Lehman Brothers LP IV ECAPS
PRESS RELEASE published on 09/21/2023 at 18:00, 2 years 2 months ago Notice to the Holders of the Preferred Securities
Published on 12/05/2025 at 02:35, 4 hours 7 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 5 hours 42 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 7 hours 37 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 7 hours 42 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 03:30, 3 hours 11 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 6 hours 51 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 10 hours 16 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 10 hours 27 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 11 hours 31 minutes ago SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance
Published on 12/04/2025 at 18:14, 12 hours 27 minutes ago Résiliation d'une convention conclue entre actionnaires
Published on 12/04/2025 at 18:00, 12 hours 42 minutes ago Informations relatives au nombre total de droits de vote et d’actions composant le capital social au 28 novembre 2025
Published on 12/04/2025 at 18:00, 12 hours 42 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 12 hours 57 minutes ago Informations relatives au nombre total de droits de vote et d’actions
Published on 12/04/2025 at 17:45, 12 hours 57 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
